NCT02218619View on ClinicalTrials.gov

Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Type 1 Diabetes
Interventions
DRUG

Tauroursodeoxycholic Acid (TUDCA)

TUDCA at 1750 mg/day x 12 months

DRUG

Sugar Pill (placebo)

Placebo

Trial Locations (1)

10032

Naomi Berrie Diabetes Center, Columbia University, 1150 St. Nicholas Ave., New York

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

Robin Goland, MD

OTHER

NCT02218619 - Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes | Biotech Hunter | Biotech Hunter